Immunocore Holdings Azioni (NASDAQ: IMCR)

Immunocore Holdings (NASDAQ:IMCR) Azioni, Quote.MetaTitle.unusual-options

Immunocore Hldgs

Immunocore Holdings plc - American Depositary Shares

Immunocore Holdings

Panoramica

Notizie

Utili

Opzioni

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Comments

Immunocore Holdings Opzioni Inusuali

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO